WASHINGTON (dpa-AFX) - Neurocrine Biosciences Inc (NBIX) released earnings for its second quarter that Increases, from last year
The company's bottom line totaled $144.4 million, or $1.39 per share. This compares with $107.5 million, or $1.06 per share, last year.
Excluding items, Neurocrine Biosciences Inc reported adjusted earnings of $296.7 million or $2.85 per share for the period.
The company's revenue for the period rose 39.5% to $959.0 million from $687.5 million last year.
Neurocrine Biosciences Inc earnings at a glance (GAAP) :
-Earnings: $144.4 Mln. vs. $107.5 Mln. last year. -EPS: $1.39 vs. $1.06 last year. -Revenue: $959.0 Mln vs. $687.5 Mln last year.
INGREZZA full year 2026 guidance was increased from a range of $2.7 billion to $2.8 billion up to $2.825 billion to $2.875 billion.
Copyright(c) 2026 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2026 AFX News
